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Abstract
Recent research suggests that anxiety disorders may be more common in later life than
previously thought. Among other factors, the presence of comorbid mood disorders and
medical illness confounds accurate assessment and diagnosis of these conditions in the
elderly. There have been few studies, however, examining the structural relationships
between anxiety and depression with older-adult samples, and even fewer have
considered the effect of medical illness on these relationships. This study examined three
established structural models of anxiety and depression, using a clinical sample of older
adults seeking treatment in a primary-care setting (N = 2,163). It was hypothesized that
the presence of comorbid medical illness would act as a moderating variable in
evaluating the fitness of these models. Results indicated that a hierarchical model
represented the most parsimonious fit to the full sample. Tests of factorial invariance
revealed variance in model fit as a function of illness severity and threat, and as a
function of illness chronicity and progressiveness. Specifically, the relationship of
somatic symptoms to anxiety varied by combined severity/threat, as well as by
chronicity/progressiveness. These findings support previous conceptualizations of the
relationship between anxiety and depression. Implications of these results for taxonomy,
assessment, and intervention are discussed.
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Structural Models of Comorbid Anxiety and Depression in a Primary-Care Older Adult
Sample: Effect of Medical Illness Severity, Threat, Chronicity, and Progressiveness on
Model Fit
In the literature regarding psychopathology in older adults, anxiety disorders have
traditionally received less attention than have other disorder categories such as dementia
and depression. Epidemiological studies based on currently accepted diagnostic criteria
(i.e., recent revisions of the Diagnostic and Statistical Manual of Mental Disorders
[DSM-III; DSM-III-R; DSM-IV; American Psychiatric Association, 1980/1987/1994)
have generally found anxiety disorders to be less common among older adults (Regier et
al., 1984/1990). Researchers of late, however, have identified higher rates of anxious
symptomatology among the elderly, suggesting that anxiety among older adults may be
more prevalent than previously thought (Lenze, Mulsant, Shear, Alexopoulous, &
Reynolds, 2001; Lynch, Compton, Mendelson, Robins, & Krishnan, 2000; Wetherell,
Gatz, & Pedersen, 2001). Anxiety in older adults is associated with higher utilization of
healthcare services (Flint, 1999; Forsell and Winblad, 1998), greater physical disability
(Lenze, Shear, Mulsant, & Reynolds, 2002), and increased risk of mortality from medical
conditions such as heart disease (Blazer, 1997; Lenze et al., 2002).
Among older adults, recognition of both anxious symptoms and syndromes can be
confounded by a number of factors. In the DSM, anxiety disorders (as well as many other
mental disorders) are defined as discrete clusters of anxious symptoms (Maser &
Cloninger, 1990). Many anxious symptoms are seen in a number of anxiety disorders,
resulting in considerable overlap between the various anxiety disorders, as well as
between anxiety and mood disorders, particularly unipolar depression. A number of

Palmer, William Michael, 2007, UMSL

p. 7

studies have established that comorbidity between anxiety and mood disorders is a
relatively common presentation (Brown & Barlow, 1992; Brown, Campbell, Lehman,
Grisham, & Mancill, 2001; Kessler, McGonagle, Zhao, Nelson, & Hughes, 1994;
Sanderson, DiNardo, Rapee, & Barlow, 1990). Among older adults, anxiety disorders and
depression co-occur with such frequency that some researchers consider the two to be
virtually indistinct in this population (Rivas-Vasquez, Saffa-Biller, Ruiz, Blais, & RivasVasquez, 2004; Stanley & Beck, 2001). Subsyndromal anxiety symptoms are also
common in the presentation of major depression, particularly in the elderly. Studies of
subthreshold anxiety and depression have indicated prevalence rates two to four times as
high as that of specific anxiety or depressive disorders. Studies focusing specifically on
the elderly have noted that these patients present with subsyndromal anxiety and
depression in primary-care settings three to six times more frequently than with either
condition reaching DSM threshold criteria (Rivas-Vasquez et al., 2004). Other
researchers have noted that ‘anxious depression’ appears to be the most common
presentation of anxious symptomatology observed in primary care settings (Flint, 1999;
Sable and Jeste, 2001). This observation is particularly germane to our discussion of latelife anxiety, given the fact that older adults with anxious symptoms are more likely to
present in a primary-care setting, attributing their somatic symptoms to medical etiologies
(Stanley & Beck, 2001).
The presence of medical illness further obstructs accurate assessment and
diagnosis of anxious syndromes in the elderly. Anxiety symptoms and disorders often
present as comorbid with medical and physical syndromes, or they may arise in response
to the onset of medical illness. In these cases, anxiety can impact the presentation and
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course of the disease, as well as presenting challenges for treatment (Pontillo, Lang, &
Stein, 2002; Roy-Byrne and Katon, 2000). Comorbid anxiety is observed most often in
diseases whose physiological symptom presentations are similar to somatic symptoms of
anxiety, such as cardiac illness, chronic obstructive pulmonary disease (COPD), asthma,
and gastrointestinal disorders (Roy-Byrne and Katon, 2000). Also, many medical
conditions produce anxiety symptoms in their own right, including cardiovascular
disease, COPD, endocrine disorders, and neurological conditions such as strokes,
Parkinson’s disease, and neurodegenerative disorders (Cohen, 1990; Lauderdale &
Sheikh, 2003; Sheikh, 2003). Physiological symptoms such as heart palpitations,
tachycardia, headaches, stomachaches, etc., are among the most common manifestations
of anxiety (Small, 1997). As a result, anxious symptoms, syndromes, and disorders are
commonly observed in the context of treatment for medical illnesses. It has been
estimated that approximately one in every five patients in the primary care setting has a
diagnosable anxiety disorder, indicating that accurate assessment and diagnosis of these
disorders plays a major role in both medical and psychological outcomes for a significant
number of patients in this setting. Nevertheless, psychiatric disorders, including anxiety
disorders, are missed in as many as half of primary-care patients, resulting in elevated
morbidity and mortality in both the psychiatric and medical illnesses, and over-utilization
of already limited healthcare resources (Zajecka, 1997). This becomes even more
apparent when it is noted that the majority of patients presenting with somatic symptoms
in primary care are not found to have a physiological etiology for their symptoms.
Consequently, elevated rates of specific anxiety disorders, particularly GAD and panic
disorder, are observed in these patients (Roy-Byrne and Katon, 2000).
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The presence of anxiety disorders in the context of medical illness is associated
with a number of negative outcomes. Particularly with comorbid depression, anxiety in
medically ill patients is associated with increased disability, higher utilization of
healthcare services, and increased mortality (Cohen, 1990; Lenze et al., 2002). The
association between anxiety and increased mortality is particularly apparent in
cardiovascular illness, although more research is needed to understand the mechanisms
involved. Lenze and his colleagues (2001/2002) have noted the dearth of studies of
anxiety in the medically ill elderly, despite evidence linking depression to increased
mortality in physical illness, as well as substantial evidence linking anxiety and
depression in this population.
Structural Models of Anxiety and Depression
As it was apparent that anxiety and depression frequently co-occur with one
another, the need to understand the exact nature of their relationship with one another
became increasingly salient to researchers. Theoretical perspectives on the relationship
between depression and anxiety appear to converge with the evidence from genetic and
neurobiological studies suggesting that both disorders share at least one common factor,
while being differentiated by unique factors. Newer, more sophisticated psychometric
approaches in the 80’s and early 90’s gave rise to structural models explaining the
relationship of anxiety and depression. An early model, proposed by Tellegen (1985),
posited that two related dimensions of affect, positive and negative, could be seen as an
underlying framework for differentiating mood and anxiety disorders. Within Tellegen’s
model, positive affect was seen to be a specific factor in depression, while negative affect
represented a general factor seen in both depression and anxiety. The model was
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consistent with Beck’s content-specificity theory of psychopathology, in which
depression contains both negative attributions about the future and ruminations about past
events (Beck & Emery, 1985).
Building on Tellegen’s work and others, Clark and Watson (1991) conducted a
review of factor analytic studies, which identified two specific factors in addition to the
general distress factor; first, a factor consisting primarily of symptoms of autonomic
arousal, relatively specific to anxiety, and an anhedonic (or low positive affect) factor
which was unique to more severe depression. Consequently, the authors proposed a
tripartite model of anxiety and depression that accounts for the generalized negative
affect factor shared by both anxiety and depression, differentiating anxiety disorders by
the presence of physiological arousal and depressive disorders by the lack of positive
affect. In a series of tests, the authors built initial support for the validity of the model in
student, adult, and patient clinical samples (Watson, Clark, et al., 1995).
Subsequent studies found support for the tripartite model in clinical samples of
children and adolescents (Chorpita, Albano, and Barlow, 1997; Joiner, Catanzaro, and
Laurent, 1996) as well as cross-cultural samples (Kiernan et al., 2001). Other studies
have addressed the issue raised by Watson, Clark et al. (1995) regarding the validity of
self-report measures, employing clinical interviews and psychophysiological studies (for
a review, see Mineka et al., 1998) in addition to self-reports. However, Burns and
Eidelson (1998) raised concerns about the validity of the tripartite model. In testing
various structural equation models on student, substance-using, and adult outpatient
samples, they found that a model containing two higher-order factors representing
depression and anxiety provided the best fit for each sample group. As a result, Burns and
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Eidelson argued that depression and anxiety were phenomenologically distinct constructs
that could not be accounted for by a single distress factor. They acknowledged, however,
that the high correlations between depression and anxiety could be the result of a single
factor that would be undetectable to cross-sectional data. Earlier perspectives on the
relationship between anxiety and depression also alluded to the temporal sequencing of
the two disorders (see Alloy et al, 1990), further pointing out the need for longitudinal
studies.
Applying evidence from previous diathesis-stress models of the development of
anxiety disorders, Barlow and his colleagues (Barlow, 2002; Zinbarg et al., 1994, Zinbarg
and Barlow, 1996) developed a three-factor model of anxiety disorders that had many
similarities to the tripartite model. The most striking similarity between the two models
was the appearance of a general factor, which Barlow labeled as ‘anxious apprehension’
that accounted for the shared variance among the anxiety disorders. Specifically,
Barlow’s model proposed that anxious apprehension was a precursor to the development
of all anxiety disorders. Each individual disorder, in turn, was differentiated by various
biopsychosocial factors unique to the disorder. Most of the differences between the
Barlow model and Watson and Clark’s model were, in fact, lexical differences. However,
one important difference between the two was in the way the general distress/anxious
apprehension factor was conceptualized. Although the shared and unique factors in the
tripartite model were characterized as three first-order factors, Barlow’s model posits that
the anxious apprehension factor (which Barlow would describe as negative affect in later
papers) is a higher-order trait factor, representing a common vulnerability to both mood
and anxiety disorders (Zinbarg and Barlow, 1996). In a preliminary test of this model
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using a sample group of outpatients seeking treatment for anxiety symptoms (N = 432),
confirmatory factor analysis produced six lower-order orthogonal factors which roughly
corresponded to the six DSM-IV disorders diagnosed in the sample group. Additionally, a
single higher-order factor emerged, correspondent to the common negative affect factor
seen in other three-factor models. Secondary analyses revealed that the general negative
affect factor could not be entirely accounted for by shared variance among the lowerorder factors or diagnostic overlap, lending further support to the validity of negative
affect as a higher-order trait vulnerability (Barlow, 2002; Zinbarg and Barlow, 1996).
By now, it has become clear that the earlier models of anxiety and depression
offered good explanations of some aspects of the relationships, while falling short in
other areas (Mineka et al., 1997). The construct of negative affect as a common factor to
both anxiety and depression, for example, has been supported in tests of both the tripartite
and hierarchichal three-factor models (Watson et al., 1995; Zinbarg and Barlow, 1996).
However, it is increasingly clear that the various anxiety disorders are differentially
related to each other, as well as to depression. It is also apparent from the work of Barlow
and his colleagues that the physiological arousal component of the tripartite model is not
sufficient to discriminate all the anxiety disorders. In an exemplary study, Brown,
Chorpita, and Barlow (1998) tested several structural models of anxiety and depression
on a sample group of outpatients presenting with anxious and depressive symptoms (N =
350). They found that the DSM-IV disorders identified in the sample group exhibited
good discriminant validity. They also found, in accordance with the tripartite model, that
each of the disorder factors was highly correlated to the negative affect factor, and that
depression was inversely correlated to positive affect. However, they also found that
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social phobia was similarly correlated to positive affect. Even more compelling, they
found that the autonomic arousal factor, which was hypothesized by the tripartite model
to differentiate anxiety disorders in general from depressive disorders, was in fact
differentially related to each of the anxious syndromes. It exhibited the strongest
relationship to panic disorder (r = .67), and had an inverse correlation to GAD (r = -.22).
In the final model, however, autonomic arousal exhibited virtually no relationship to
either social phobia or OCD, supporting Barlow’s view that each of the anxiety disorders
has a unique component that differentiates it from the others.
In light of this evidence, Mineka and her colleagues (1998) proposed an
integrative hierarchical model of anxiety and depression that incorporates empirically
supported features of both the tripartite and hierarchical models proposed previously.
This integrative model retains negative affect as a general distress factor common to
anxiety and depression, and further posits that negative affect may play a pervasive role
in a number of additional syndromes as well. The model goes on to recognize the
heterogeneity of unique components of each disorder, calling for a better understanding
of the nature of these factors. Finally, the integrative model points out that individual
disorders may differ in the proportion of shared and unique factors observed in each
syndrome. This observation has been noted in subsequent comorbidity research. For
example, GAD and depression have been found to have a shared diathesis, while their
environmental determinants are largely unique (Brown, Campbell, Lehman, Grisham,
and Mancill, 2001).
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Model Testing With Older Adult Samples
Although the existing models of anxiety and depression have been extensively
researched in younger adult, child, and adolescent samples, there has been considerably
less investigation of the validity of these models in older adults. A body of literature
began to emerge in the 1990’s suggesting that older adults may experience affect
differently than their younger counterparts, drawn primarily from studies of late life
depression (Gurian and Miner, 1991; Shapiro, Roberts, and Beck, 1999). For example, a
comparative factor analysis conducted with young (n = 207), middle age (n = 231), and
older adult (n = 828) samples revealed that experiencing positive affect was less salient to
older adults that to their younger counterparts, while the experience of anxiety in older
adults was more directly related to fear than to other factors (e.g. guilt, shame, worry)
that were more salient in the younger samples (Lawton, Kleban, and Dean, 1993).
Nevertheless, only recently have researchers begun to test the established models of
anxiety and depression in older adult samples.
Previous research employing younger adult samples had indicated that
consideration of both cognitive and affective symptoms of anxiety and depression
improves discrimination of each disorder (Jolly, Dyck, Kramer, and Wherry, 1994). In an
attempt to determine whether the same held true in the elderly, Shapiro, Roberts, and
Beck (1999) undertook an initial investigation of cognitive and affective structure of
depression and anxiety in a sample of community-dwelling older adults (N = 283). They
chose to simultaneously test Beck’s (1985) cognitive content-specificity hypothesis along
with Watson, Clark, and Carey’s (1988) positive and negative affective model The
researchers first performed a series of factor analyses on measures of anxiety and
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depression that were theoretically based on each model. For the cognitive contentspecificity hypothesis, the Cognitions Checklist (CCL; Beck et al., 1987) was examined,
and the Positive and Negative Affect Schedule (PANAS; Watson, Clark, and Tellegen,
1998) was evaluated for affective structure. Factor analyses of the CCL with younger
adult samples had produced a two-factor solution corresponding to the Depressive- and
Anxious- Cognitions subscales contained in the measure (Beck et al., 1987; Steer, Beck,
Clark, and Beck, 1994). In the older adult sample, however, the measure separated into
three factors; a health-anxiety factor derived from the original CCL Anxiety Scale, and
two separate depression factors, representing cognitions about declining social
functioning and thoughts of low self-worth. A similar analysis of the PANAS scales
maintained a two-factor solution similar to that suggested by Watson et al., although
some individual items were excluded for lack of specificity. However, it should be noted
that the items loading on the Negative Affect subscale were primarily associated with
anxiety (e.g., ‘nervous,’ ‘jittery,’ ‘scared’), while items related to guilt and shame failed
to load. This finding was consistent with those of Lawton et al. (1993) that ruminations
about past events are less salient to elders than present concerns, particularly healthrelated anxiety.
In the second set of analyses, the revised CCL and PANAS subscales were
correlated with symptom measures of depression and anxiety to determine if the same
correlations observed in younger samples would hold true in the older adult sample
group. Subsequently, hierarchical multiple regressions were conducted to see if the CCL
and PANAS subscales independently predicted anxiety and depressive symptoms. These
analyses revealed stark differences between the older adult sample and younger adults. In
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terms of cognitions, they found that anxious cognitions in older adults related to both
anxious and depressive symptomatology, in contrast to younger samples where anxious
cognitions specified anxious symptoms. Cognitions of worthlessness were also related to
both anxious and depressive symptoms, while thoughts of social loss generally were not
associated with either anxious or depressive symptomatology in the elderly sample group.
By comparison, thoughts of negative self-worth in younger samples tended to be
associated differentially with depression (Roberts and Gotlib, 1997). With regard to
affect, although the Negative Affect factor was associated with general distress in the
elderly sample, lack of positive affect did not differentiate between depressive and
anxious symptom presentations. This study was limited in that 1) it relied mainly on selfreport measures, 2) the measures were completed in a group setting, which may have
suppressed self-disclosure, and 3) the sample was relatively high-functioning, and
generally asymptomatic. Nevertheless, the study suggested that older adults think
differently about anxiety and depression than do their younger counterparts. Also,
although the shared affective components of anxiety and depression may be similar
across age groups, factors differentiating the disorders may vary as a function of
advanced age.
Subsequent model tests of anxiety and depression in older adults have similarly
failed to demonstrate invariance in factor structure between older and younger samples.
Meeks, Woodruff-Borden, and Depp (2003) replicated Joiner’s (1996) test of one, two,
and three-factor models of anxiety and depression, using a large (N = 1,429) randomly
generated sample of older adults, as well as a smaller (N = 210) convenience sample of
participants recruited from various community sites. In both samples, the researchers
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found that a two-factor model provided the best explanation of the data, suggesting that
the general distress factor observed in younger samples is qualitatively different from the
experience of older adults. Wetherell, Gatz, and Pedersen (2001) also obtained a twofactor solution in a longitudinal sample of middle-aged and older (M = 60.9 years)
Swedish twins. Similar to Shapiro and her colleagues, these researchers found that
general distress in older adults appeared to be more closely related to anxiety than to
depression.
One of the key limitations of Shapiro’s study, as well as many previous studies in
this area, was the use of a relatively high-functioning, community-dwelling sample
group. In their discussion, Shapiro and her colleagues rightly noted the possibility of a
differential structure of anxiety and depression emerging in a sample of treatmentseeking elders. Addressing this issue, J.G. Beck and her colleagues (2003) replicated
Shapiro’s analysis of the CCL and PANAS with a sample of older adults presenting for a
clinical trial of cognitive-behavioral therapy for GAD (N = 83). The researchers chose
this relatively homogenous sample for two important reasons. First, they wished to avoid
confounding their results through excessive variance in presentations, while still
capturing a representative clinical sample. Citing earlier evidence of the wide prevalence
of GAD in older adults, the authors argued that a sample group of GAD patients met this
requirement. Second, the authors noted evidence that GAD itself may function as a
higher-order factor in older adults, thus allowing them to extend the conceptualization of
this syndrome in the elderly (Beck et al., 2003). The initial confirmatory factor analysis
with the PANAS produced a three-factor solution, with negative affect separating into
two factors. The two negative affect factors represented constructs similar to the findings
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of Shapiro et al., with anxiety and anger loading on one factor and guilt and shame
loading on the other. In Shapiro’s analysis, however, the guilt/shame items were dropped,
leaving a two-factor model; in the Beck analysis, retention of the guilt/shame factor
proved a better fit to the data. Exploratory and confirmatory factor analyses of the CCL
items with this sample produced a two-factor solution, although there were notable crossloadings on several items. In contrast to Shapiro’s results, a three-factor solution did not
improve model fit. Intercorrelations between the CCL and PANAS subscales, as well as
between these subscales and established measures of depression and anxiety, supported
convergent validity of the depression measures, while the anxiety subscales were less
clearly convergent. Likewise, a series of hierarchical regressions found that the measures
of depression added predictive power to the regression equations for anxiety, but the
anxiety measures did not produce the same effect in predicting depression. Of particular
note, each of the subscales of the cognitive and affective measures added significant
predictive power to both state and trait anxiety measures, suggesting that long-standing
generalized anxiety plays an etiological role in the emergence of at least the anxious
form of late-life depression (see Lynch et al., 2000, for a description). Overall, this study
added to the growing evidence suggesting that older adults experience anxiety differently
than their younger counterparts.
There has been at least one direct test of a tripartite structural model of anxiety
and depression undertaken in a clinical sample of older adults (Cook, Orvaschel, Simco,
Hersen, and Joiner, 2004). This test also extended the existing literature by employing a
structured interview measure, in addition to self-reports, to test the convergence of the
tripartite model in a clinical outpatient sample of older adults (N = 131). Although the
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results of this study supported adequate fit of the tripartite model, the authors noted that
the physiological arousal factor, which is posited to be anxiety-specific, was significantly
correlated with a measure of depressive symptoms (i.e., the BDI; r = .54, p = .001), as
well as with SCID-IV diagnoses of depression (r = .47, p = .001). Consistent with Beck
et al., (2003), as well as earlier theoretical perspectives on the temporal relationship
between anxiety and depression (Alloy et al., 1990), these results suggest that generalized
anxiety plays a role in anxiety, depression, and comorbid states in older adults, perhaps as
a higher-order factor (Mineka, Clark, and Watson, 1998; Zinbarg and Barlow, 1996).
Summary of the Present Literature
The shortcomings of our current categorical system for classifying mental
disorders are perhaps most glaring when it comes to differentiating between anxiety and
depression. The presence of a great number of symptoms that are common to both
anxious and depressive syndromes seems to argue for a nosology based on something
other than discrete symptom clusters. Ironically, these very shortcomings have served to
illuminate the shared variance of anxiety and mood disorders, and have formed the basis
for development of theoretical models to address these issues. Improving differential
diagnosis of anxiety and depressive disorders will necessitate development of
psychometrically-sound and theoretically-grounded measures that represent the
experience of anxiety and depression across multiple populations. This becomes
particularly important in the context of late-life, given mounting evidence that older
adults experience anxiety and depression differently than their younger counterparts. In
the elderly, symptom presentations become increasingly diffuse and somatic, giving rise
to new dilemmas in diagnosis. Additionally, since most anxiety and mood disorders begin
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earlier in life and increasing age is associated with declining recall, over-reliance on selfreport measures becomes increasingly problematic with this population. Clinicianadministered measures that are reliable and valid with older adults form an essential piece
of the puzzle in understanding and recognizing anxiety disorders in older adults. These
problems are often exacerbated in the elderly by the presence of medical illness.
Anxiety associated with medical illness is a particularly common occurrence
among the elderly (Sheikh, 2003). Epidemiological studies, as well as longitudinal data,
have indicated that a significant proportion of persons with chronic medical conditions
also meet criteria for an anxiety disorder. Since the majority of older Americans suffer
from chronic medical illness, we can expect an increased prevalence of comorbid anxiety
symptoms and disorders in this group (Hybels and Blazer, 2003; Nguyen, Goldberg, &
Sheikh, 1999; Small, 1997). Anxiety symptoms and discrete disorders, while relatively
uncommon in community-dwelling older adults, are much more prevalent in medically ill
elders. This increased prevalence is associated with increased morbidity and mortality,
particularly in the context of comorbid depression (Lenze et al., 2000). There are several
confounding issues encountered in recognizing anxiety in the context of medical illness
that are of particular importance to older adults. Cognitive decline, comorbid depression,
pharmaceuticals, substance use, and cohort effects can all serve to produce or mask
anxious symptoms in the elderly patient (Nguyen et al., 1999; Small, 1997).
Nevertheless, there have been no examinations of the structure of anxiety and depression
conducted with medically ill older adults.
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Hypotheses
Previous examinations of the relationship between anxiety and depression in older
adults have usually relied on convenience samples taken from community or clinical
settings. These samples have typically been relatively high-functioning, medically
healthy older adults, with relative homogeneity regarding pre-existing psychiatric
diagnoses. This study extends the current literature by employing a medically
heterogenous sample of elders presenting in primary-care medical settings. This approach
addresses concerns expressed by others in this research area (see Cook et al., 2004)
regarding inclusion of medical comorbidity as a needed extension of the current literature
in late-life anxiety and mood disorder comorbidity. To this end, information on comorbid
medical conditions in this sample was used to provide a basis for generation of
subsamples that varied in medical illness severity, threat, chronicity, and progressiveness.
The study tested three models of anxiety and depression comorbidity, based on
models that have previously been examined in relatively healthy older-adult (Cook et al.,
2004; Meeks et al., 2003) and wider age-range adult (Burns & Eidelson, 1998) samples.
This study examined the fit of each model to the overall sample, before examining
whether the best-fitting of these models would prove invariant in subsamples defined by
varying levels of medical illness severity, threat, chronicity, and progressiveness. The
following hypotheses were proposed:
1. A hierarchical model, with two first-order factors (representing depression and
anxiety) subsumed under a higher-order, non-specific distress factor, will provide
the best overall model fit.
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2. The presence of medical illness is a moderating variable in the relationship
between anxiety and depression in older adults. The structural model providing
most parsimonious fit in the full sample (i.e., the hierarchical model) will prove
non-invariant across subsamples representing various constructs of medical
illness. Thus:
(a) The hierarchical model will vary in fit between subsamples representing lower
and higher levels of illness severity and threat. Severity is defined as the
likelihood that participant medical conditions would require one or more days of
hospitalization. Threat is defined as the likelihood that sequelae of present
medical conditions would result in the death of the patient.
(b) The model will vary in fit between subsamples representing lower and higher
levels of illness chronicity and progressiveness. Chronicity is defined as the
likelihood that participant medical illnesses will require medical treatment,
beyond that which the participant could independently manage, for 6 months or
longer. Progressiveness is defined as the likelihood that participant medical
illnesses will increase in severity over time, regardless of treatment.
Methods
Participants
Participants for the study were derived from a sample group of older adults who
originally participated in the Primary Care Research in Substance Abuse and Mental
Health for the Elderly (PRISM-E; Levkoff, Chen, Coakley et al., 2004) multisite
randomized trial of integrated behavioral healthcare for older adults. The sample group
was derived from persons aged 65 years or older who originally presented at one of 34
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primary care clinics across eleven sites participating in the PRISM-E study (N = 23,828).
The study sites included six Department of Veterans’ Affairs Medical Centers (VAMC),
three community health centers, and two urban hospital networks (Levkoff et al., 2004).
Each potential participant completed a brief screening procedure, consisting of the12item General Health Questionnaire (GHQ-12; Goldberg & Williams, 1988) to assess
symptoms of mental distress, two questions to assess suicidal thoughts (Spitzer et al.,
1994), and three questions regarding alcohol consumption (Sobell, Sobell, Leo, &
Cancilla, 1988).
A total of 6,430 participants met initial screening criteria for the presence of
psychological distress, suicidal ideation, or at-risk drinking. These participants were then
invited to participate in a baseline assessment that included sections of the MINI
International Neuropsychiatric Interview (MINI; Sheehan et al., 1998), the Center for
Epidemiological Studies Depression Scale (CES-D; Radloff, 1997), and the Beck
Anxiety Inventory (BAI; Beck, Epstein, Brown, & Steer, 1988), as well as measures of
alcohol consumption and a medication review. Of those invited to participate, 3,225
either declined to participate or were excluded because they were already receiving
mental health or substance use treatment. Of the 3,205 participants who did participate in
the baseline assessment, 992 did not meet baseline criteria for an anxiety, depressive, or
substance use disorder, and were excluded on that basis. Additionally, 73 participants
were excluded due to diagnoses of hypomanic or psychotic disorders, and 118
participants did not complete the baseline assessment. Of the remaining 2,244 cases, 87
were deleted listwise due to missing data on a MINI question about generalized anxiety
that was to be used in the construction of the observed variables for the model. The
remaining participants (N = 2,163) formed the sample group for the study. A frequency
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comparison of key demographic variables between the excluded cases and those in the
final sample revealed that the excluded participants were more likely to be black,
between 65 and 74 years of age, never married, and more likely to report that they were
just getting by financially (Table 1). Additionally, the final sample group was
disproportionately male, which can probably be explained by the number of VAMC
recruitment sites employed by the PRISM-E investigators. Comparison of the two groups
on observed variables used in the models tested (Table 2) shows that the excluded
participants generally reported higher levels of distress, although the groups were not
statistically different from one another.
Measures
Mini International Neuropsychiatric Interview—The MINI International Psychiatric
Interview (Sheehan, Lecrubier, Sheehan, et al. 1998) is a brief structured interview for
diagnosis of DSM-IV and ICD-10 psychiatric disorders. The interview is organized in a
series of 16 modules, representing various DSM-IV diagnostic categories (Table 3). Each
module consists of a series of questions assessing current symptoms of each disorder that
may be experienced by the patient. The MINI has displayed adequate inter-rater and test
retest reliability, and demonstrates good convergent validity with more comprehensive
structured interviews (Lecrubier et al., 1997; Antony & Barlow, 2002). For this study,
items derived from the modules representing anxiety and mood disorders were summed
to construct observed variables representing subgroups of interest. (Table 4)

Center for Epidemiological Studies Depression Scale (CES-D)-----The CES-D (Radloff,
1977) is a 20-item self report measure designed for use in epidemiological studies to
screen for the presence of depressive symptomatology. It possesses good internal
consistency ( = .85 [non-patients], .90 [patients]), and test-retest reliability (r > .54 at 6
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months). Studies conducted with older-adult samples maintained similar numbers
(Lewinsohn, Seeley, Roberts, & Allen, 1997). Radloff (1977) reported a consistent fourfactor structure (dysphoria, well-being, somatic complaints, and interpersonal difficulties)
in factor analyses of the measure; this structure has been replicated in other studies as
well (see Antony & Barlow, 2002). The CES-D appears to be an adequate screening
instrument for depression, with good sensitivity; however, it has been noted that the CESD produces a high number of ‘false positives,’ limiting its diagnostic utility somewhat
(Antony & Barlow, 2002). For this study, observed variables were constructed from the
factors identified by Radloff (1977) as well as a summary of all measure items.

Beck Anxiety Inventory (BAI)-----The BAI (Beck, Epstein, Brown, & Steer, 1988) is a 21item self-report measure of anxiety severity. It displays adequate internal consistency (α
= .60) and good test-retest reliability (r [one week] = .75). Correlations with clinicianadministered anxiety scales were approximately .50, while correlations with clinicianadministered depression scales were lower (approximately .25). Antony & Barlow (2002)
reported that factor analysis of the BAI with an adult outpatient sample produced a twofactor solution (anxious cognitions and somatic arousal). This two-factor solution has
also been observed in outpatient samples of older adults (Wetherell & Arean, 1997).
These factors, as well as a summary variable, were employed to construct the observed
BAI variables for this study.
Physical Health Indicators—The PRISM-E baseline interview also gathered information
regarding medical comorbidity. Participants in the baseline interview had an average of
4.7 comorbid medical diagnoses (SD = 2.5; Levkoff et al., 2004). For purposes of
invariance testing, the study employed self-reports from the PRISM-E baseline of
medical diagnoses across 22 separate disease categories (Table 5). Each medical
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diagnosis was assigned a separate weight for severity, threat, chronicity, and
progressiveness based on mean ratings of each variable (Table 6) derived from a survey
of nursing students enrolled in the MSN program at UM-St. Louis (N = 63). In this
survey, the nursing students were asked to assign a rating to each of the 22 illness
categories for each of the variables, using a 5-point Likert-type scale representing a
percentage-range likelihood of each variable (see Appendix). Inter-rater agreement was
adequate, with an intra-class correlation coefficient of 0.89 for the full survey. A series of
Pearson product-moment correlations conducted between the four medical illnesses
constructs on each category of medical illness revealed significant correlation between
the severity and threat variables, as well as between the variables of chronicity and
progressiveness. Combining the ratings of severity and threat produced high item
consistency (Cronbach’s ά = .917), with solid inter-rater reliability (Intraclass correlation
coefficient = .917). Combining ratings for chronicity and progressiveness produced
similar results (Cronbach’s ά = .897; intraclass correlation = .897) Variables representing
these combined categories were computed using a weight for each medical illness created
by summing the means for severity and threat, and summing the means for chronicity and
progressiveness. Each illness category was multiplied by the combined weights, and the
resulting sum of weighted illnesses was used to represent the constructs of severity/threat
and chronicity/progressiveness.

Descriptive Statistics
Correlational analysis of the observed variables for this study supported the utility
of these variables in representing the latent variables of interest (Table 7). BAI factors
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demonstrated the highest correlations with each other and with the MINI summed anxiety
items. CES-D factor variables and MINI items representing factors associated with
depression (summed depression, positive affect, negative affect) were also highly
correlated with one another. Conversely, the BAI and MINI anxiety variables
demonstrated clearly lower correlations with the CES-D and MINI depression variables.
Compared to a community-dwelling sample of older adults (N = 281; Morin, Landreville,
Colecchi, McDonald, Stone, & Ling, 1999), participants in this sample scored lower on
the BAI subscales. This may reflect the fact that our sample group was predominantly
(78.1%) male; older males have been shown to produce significantly lower BAI scores
than older females (Owens, Hadjistavropoulos, & Asmundson, 2000). A recent validity
study for the CES-D employing a sample of community-dwelling elders (N = 318;
Haringsma, Engels, Beekman, & Spinhoven, 2004) recommended a cutoff score of 22 or
above for diagnosing clinically significant symptoms of depression. In our study sample,
50.7% of participants scored 22 or above on the CES-D. Compared to large
epidemiological studies (for example, Zung, Broadhead, & Roth, 1993), this sample
reported higher levels of clinically significant depressive symptoms; however, the
presence of psychiatric symptomatology was an inclusion criteria for the original study.
Means and standard deviations for each of the observed variables appear in Table 8.

Data Analysis
To evaluate the question of whether medical illness would affect the structural
relationship between anxiety and depression in this sample, an invariance-testing
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approach was employed. To test invariance between the groups based on differences in
medical illness severity and threat, the full sample was split into upper and lower thirds,
using the summaries of medical comorbidities weighted by the combined severity/threat
scores obtained from the nursing student survey. Factorial invariance was assessed by
comparing model fit between the subgroups. A similar strategy was employed to test
invariance between the groups based on chronicity/progressiveness.
For the tripartite model supported in the Cook et al. (2004) study, CES-D items
loading on the ‘somatic’ factor and BAI items loading on the ‘somatic arousal’ factor
were hypothesized to represent the latent ‘physiological hyperarousal’ variable. CES-D
items loading on the ‘well-being’ factor and MINI items indicating positive affect were
hypothesized to represent the latent ‘positive affect’ variable. The ‘negative affect’ latent
variable was represented by CES-D items loading on the ‘dysphoria’ factor and BAI
items loading on ‘anxious cognitions.’ The measurement/confirmatory model for the
tripartite model appears in Figure 1.
For the hierarchical two-factor model from Burns & Eidelson’s (1998) study, the
first-order ‘anhedonia’ factor was represented by CES-D items loading on the
‘anhedonia’ and ‘somatic factors, and MINI items indicating positive affect. The ‘nonspecific depression’ factor was represented by CES-D ‘dysphoria’ items, and MINI items
indicating summed depressive symptoms, as well as MINI negative affect items. The
‘non-specific anxiety’ factor was represented by BAI items loading on the ‘anxious
cognitions’ factor, and MINI items indicating both summed and non-specific symptoms
of anxiety. The ‘somatic’ factor was represented by BAI items loading on the ‘somatic
arousal’ factor and MINI items indicating physiological arousal. The measurement model
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for the Burns-Eidelson model appears in Figure 2, with the structural model appearing in
Figure 4.
For the hierarchical three-factor model from Meeks et al. (2003), the first-order
‘depression’ factor was represented by CES-D well-being items and MINI items
indicating depressive symptoms. The first-order ‘anxiety’ factor was represented by BAI
and CES-D somatic subscales, BAI anxious cognitions, and the MINI items indicating
anxious symptoms. The measurement model appears in Figure 3, with the structural
model appearing in Figure 5.
Models were constructed and tested using AMOS (Analysis of Moment
Structures) version 4.0 (Arbuckle, 1999). Chi-Square tests of model fit were employed as
an initial assessment of model fit. Given the effect of large sample sizes on the chi-square
distribution, additional fit indices were also examined. Absolute-fit indices, including the
Goodness-of Fit Index (GFI; Hu & Bentler, 1995) and the Adjusted Goodness-of-Fit
Index (AGFI; Hu & Bentler, 1995) were employed to address the sample size issue with
the chi-square distribution, providing a comparison of fit between the hypothesized
model and none at all. The AGFI provides an additional adjustment for degrees of
freedom, affording a more specific test of model fit. The root-mean square error of
approximation (RMSEA; Stieger & Lind, 1980) was also used to evaluate fit of these
models. This measure of incremental fit provides a confidence interval around its point
estimate, yielding further specificity of model fit (Smith & McMillan, 2001).
Confirmatory factor analyses were conducted with each measurement model to evaluate
adequate representation of each latent variable by the selected observed variables. The
CFA model for the tripartite model, along with the structural Burns-Eidelson and
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hierarchical models, were then tested and compared for fit to the full (N = 2,163) PRISME sample to test Hypothesis 1.
Based on the results of model testing with the full sample, the hierarchical model
was selected for invariance testing with selected subgroups to evaluate Hypotheses 2(a
and b). Model selection for this phase of analysis reflected adequate statistical model fit,
as well as judgment of parsimony and theoretical congruence. The selected model was
then tested for invariance, using the subsamples previously defined for each medical
illness variable as well as the combination-weighted variables indicated by correlational
analysis of the illness categories.
Power Analysis
Ullmann (2001) provided a general estimate that sample sizes of > 200 are
adequate for small to medium structural models. Based on this rough estimation, the
proposed sample group appears to provide adequate power to test the proposed
hypotheses. For a more exact analysis, we employed estimates provided by MacCallum,
Browne, & Sugawara (1996) of sample size at p = .80 to detect an adequate root-mean
square error of approximation (RMSEA). For the tripartite model, based on df = 25, a
minimum sample size of N = 363 was estimated. For the Burns-Eidelson model, df = 10,
requiring a minimum sample of N = 782. For the Meeks model, df = 15, and the
recommended minimum sample (by extrapolation) is approximately N = 555. Given an
overall sample of N = 2,163, employing upper and lower thirds produced subsamples
with adequate sample size to evaluate each model with power exceeding 0.8.
Results
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Confirmatory factor analysis of measurement models for each model revealed that
the observed variables reliably measured the latent variables of interest (Table 9). All
observed variables loaded significantly on their respective factors for each of the
measurement models tested (p < .01). Testing of the full structural models revealed
adequate statistical fit for both the tripartite and hierarchical (Meeks) models (tripartite
model—χ2 (3) = 10.4, p = .0015; hierarchical-- χ2 (6) = 22.7, p < .001). The BurnsEidelson model did not demonstrate adequate fit to the full sample ( see Table 10 for
additional fit indices).
The hierarchical model was chosen for testing of invariance on the medical-illness
variables of interest. Although the tripartite model could be judged as parsimonious on
the basis of fewer overall parameters, the observed variables in the hierarchical model
appear to better represent the hypothesized latent variables. Also, more of the paths from
latent to observed variables were free to vary in the hierarchical model, providing greater
construct validity for that model. Finally, the hierarchical model was believed to best
represent the theoretical relationship between the three factors, as the most recent models
in the literature suggest negative affect is a higher-order factor common to both anxiety
and depression, while low positive affect is more specific to depression and physiological
arousal is more specific to anxiety (Mineka et al., 1998; Teachman, Siedlecki, & Magee,
2007).
An invariance test using the combined severity-threat weighted summary of
medical conditions revealed non-invariance between the low severity/threat (n = 705) and
high severity/threat (n = 750) subsamples. Specifically, the BAI ‘somatic complaints’
items were differentially related to the anxiety variable between groups. An examination

Palmer, William Michael, 2007, UMSL

p. 32

of the regression paths revealed that the BAI somatic subscale was more highly
correlated to the anxiety factor in the high severity/threat subsample (r = .57; Figure 6 )
than in the low severity/threat subsample (r = .25; Figure 7). A summary of the modelfitting sequence to the severity/threat groups appears in Table 11.
An invariance test using the combined chronicity/progressiveness weighted
summary of medical conditions revealed non-invariance between the low
chronicity/progressiveness (n = 716) and high chronicity/progressiveness (n = 733)
subsamples. Again, the BAI somatic complaint subscale was found to vary between
groups. Examination of regression paths revealed that the correlation of the BAI somatic
subscale with the anxiety factor was higher for the high chronicity/progressiveness group
(r = .58; Figure 8) than for the low chronicity/progressiveness group (r = .25; Figure 9).
A summary of the model-fitting sequence to the chronicity/progressiveness groups
appears in Table 12.
Discussion
The present study extends the current literature in several important ways. First,
the study employed a sample group of older adults presenting in a primary-care setting.
This corresponds to previous literature suggesting that older adults are more likely to
present to primary-care providers with anxious and depressive symptoms than younger
adults, who would be more apt to utilize specialty mental-health providers (e.g., Levkoff,
Chen, Coakley et al., 2004; Bartels, Coakley, Zubritsky, et al., 2004). This approach,
although technically a convenience sample, provides better external validity since it is
selected on the basis of characteristics known to exist in the larger population. Further
supporting the generalizability of these results, the sample group was drawn from a large
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multisite clinical trial, with a range of both demographic characteristics and
psychopathology generally reflective of a larger population. The large sample size
provided adequate power to detect effects, both in the overall model-fit and in subsequent
invariance testing. Most importantly, this sample included a range of comorbid medical
conditions that allowed testing of factorial invariance on the basis of several important
illness constructs.
In regard to the first hypothesis, the hierarchical model of comorbid anxiety and
depression, with a second-order distress factor common to both conditions, provides
adequate fit in the full sample. This extends the results found by Meeks et al. (2003) in
probability and convenience samples to a larger, primary-care sample with information
regarding a full range of comorbid medical illnesses. This study provides further support
for the existence of a general-distress factor that underlies more specific expressions of
psychopathology. Hierarchical models of this type have previously been fitted to discrete
anxiety disorders (Zinbarg & Barlow, 1996) as well as anxiety and depression (Brown,
Chorpita, & Barlow, 1998), and have been proposed to account for a wider range of
psychopathology (Mineka, Watson, & Clark, 1998; Krueger, Markon, Chentsova-Dutton,
Goldberg, & Ormel, 2003). Although the tripartite model adequately fit the sample as
well, the hierarchical model was chosen for invariance testing on the basis of congruence
with previous literature noting the differential relationship of negative affect to discrete
anxiety disorders (Mineka, Watson, & Clark, 1998). Previous research has elucidated
differences in the phenomenology of comorbid anxiety and depression in older adults; in
particular, the prevalence of mixed anxiety-depressive states and subthreshold symptom
presentations point to a common factor impacting both syndromes (Shapiro, Roberts, &
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Beck, 1999; Rivas-Vasquez et al., 2004). A recent SEM examination of a tripartite model
in a cross-sectional community sample of adults aged 18-93 (Teachman, Siedlecki, &
Magee, 2007) posited a second-order negative-affect factor, similar to the models
proposed earlier by Meeks et al. (2003), as well as by Zinbarg & Barlow (1996) and
Mineka et al. (1998). This research suggests a continuing evolution toward
conceptualization of negative affect as a higher-order factor common to anxiety and
depression, and possibly to a number of other disorders as well.
The hierarchical model was found to vary between low and high-severity/threat
subsamples, as well as between low and high-chronicity/progressiveness subsamples, in
the relationship of somatic symptoms of anxiety to the latent anxiety variable.
Specifically, somatic symptoms of anxiety were more strongly related to anxiety in the
subsamples that were higher on each construct. This finding represents an important
extension of the current literature, as it provides a better understanding of the impact of
medical illness on the somatic expression of anxiety. Researchers have decried the lack of
empirical data regarding this issue, arguing for the need of a better understanding of the
presentation of anxiety in the context of medical illness (Farrell, 1997; House & Stark,
2002; Harter, Conway, & Merikangas, 2003).
Awareness of the direct relationship of somatic symptoms of anxiety to illness
severity, threat, chronicity, and progressiveness has a number of important implications
for assessment and treatment approaches in elderly patients. In spite of long-established
data suggesting that anxiety disorders are common in the elderly, development of reliable
and valid measures for anxiety in the medically ill elderly has traditionally lagged behind
development of measures for other disorders, particularly depression (Hersen, van
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Hasselt, & Gorenczy, 1993; Neal & Baldwin, 1994). In fact, there is still no universally
accepted measure of late-life anxiety in general that has been sufficiently validated with a
representative sample of elders (Ayers, Sorrell, Thorp, & Wetherell, 2007). The
variations in responding to the BAI somatic-symptom questions noted in this study
concur with other researchers who have pointed out its lack of specificity in older-adult
samples, stemming from its reliance on somatic symptoms which are often elevated in the
medically ill elderly (Wetherell & Gatz, 2004). These results underscore the need for
increased specificity in assessments for anxiety in the medically ill elderly. Given the
evidence linking anxiety to increased morbidity and mortality in the medically ill elderly,
the development of reliable, valid, and accessible measures for use in clinical practice
should be prioritized (Kim, Braun & Kunik, 2001; Ball, Goddard & Shekhar, 2002;.Stein,
Sherbourne, Craske et al., 2004).
In terms of developing interventions germane to older adults with medical
comorbidity, results of this study failed to indicate significant differences between
healthy and ill adults in the relationship of anxious cognitions to anxiety. This suggests
that interventions targeting anxious cognitions, which have been shown to be generally
effective in older-adult samples (Ayers, Sorrell, Thorp, & Wetherell, 2007) should be
effective in those with medical comorbidities as well. The increased presence of somatic
symptoms in the medically ill suggests that behavioral interventions for anxiety should be
offered routinely in the course of medical treatment of illnesses known to show a higher
association with anxious symptoms, such as cardiac disease and COPD.
Factorial invariance testing of the selected model raised several issues that had to
be addressed. First, it was necessary to develop a reliable and valid measure of medical
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illness that would serve as the basis for dividing the full sample into the groups upon
which the model would be evaluated. One of the considerations that influenced selection
of the PRISM-E dataset for this study was the availability of sufficient data on medical
illness to allow construction of such a measure. In fact, the screening and baseline
surveys included information on a variety of medical questions, including healthcare
utilization, pharmaceutical usage, self-perceptions of physical health, functional health
status, and comorbid medical conditions (see Levkoff et al., 2004, for a full description).
A number of potential strategies were considered for utilizing the available data to
develop the medical-illness measure. One strategy involved using individual medicalillness variables, such as the SF-36 Physical Health subscale, to increase power by
allowing more of the sample group to be employed. However, each of the potential
variables raised questions regarding its validity as a stand-alone indicator of medical
illness. The SF-36 Physical Health subscale, for example, could be criticized for relying
solely on self-reported perceptions of health. Reports of medication usage raised a similar
issue of veracity as well as proving to be too heterogeneous to draw clear conclusions
from. The Cornell Healthcare Utilization Scale measures hospital admissions and
outpatient treatment utilization. This option would likely have produced a negatively
skewed distribution of scores, given anecdotal reports that hospitalization generally
implies an acute illness state (Lee, personal communication). This type of distribution
would have failed to lend concurrent validity to the current approach, although the issue
would have been a statistical one, rather than actual disconfirmation of the survey
findings.
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In an attempt to establish convergent validity, several strategies were explored
that would combine the existing variables into a medical-illness severity or chronicity
variable by employing an interaction or cross-tabulation strategy (for example, see
Sheikh, Cassidy, Doriaswamy, et al. 2004). Unfortunately, employing such strategies
with the study sample produced subsamples that lacked sufficient power to adequately
test the proposed models. Therefore, the decision was made to utilize a single measure,
the summed medical-illness checklist, to define the construct of interest. This strategy
maximized statistical power by allowing use of the full sample. Simply summing the
number of medical conditions present in participants, however, failed to provide
information regarding the variables of interest in this study (i.e., illness severity,
chronicity, progressiveness, and threat).
To address this issue, a weight was assigned to each medical condition in the
sample, indicating the level of each variable of interest. A summary of each condition
with the weights added would then allow assessment of severity, threat, chronicity,
and/or progressiveness. It was suggested that these weights might be generated by
obtaining a consensus rating of each illness category on the measures of interest by a
sample of persons who could be considered to have authoritative knowledge regarding
these medical conditions (Lee, personal communication, 2006). This strategy has been
employed in similar studies where illness severity was a variable of interest (Farley &
Hill, 2005; Chawistiak, Rosenheck, McEvoy et al.,2006). Physician rating of illness
severity and chronicity forms the basis for well-established measures of illness severity
and chronicity, such as the Cumulative Illness Rating Scale (Linn, Linn, & Gurel, 1968).
A survey (see Appendix) was administered to a sample of masters-level nursing students,
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who were considered to be familiar with both the disease categories in our checklist and
the variables of interest. Tests of inter-rater reliability conducted with this sample
indicated that the survey participants reached an acceptable level of agreement in rating
the illness on each variable. However, the homogenous nature of the survey sample calls
any statement of reliability into question. The nursing students surveyed primarily come
from an acute-care hospital background. Nurses from other settings, such as long-term
care or community practice, may produce very different ratings of these illnesses, based
on their perspective (Steffen, personal communication). Healthcare professionals from
other disciplines (e.g., medical doctors) and family caregivers may offer still more
variation in ratings. Considering this variation in future studies would add external
validity to our weights. This weighting system also limited the utility of our results in the
sense that it rates levels of severity, threat, chronicity, and progressiveness by condition.
However, this approach fails to account for individual differences between participants
on the variables of interest. Cross-validation of this measure with SF-36 or Cornell Scale
data would help to address this issue and lend a degree of concurrent validity to our
assumptions regarding medical illness.
The decision to create variables based on combined constructs of severity/threat
and chronicity/progressiveness was based on a series of Pearson product-moment
correlations looking at the relationships between the four constructs within each illness
category. Results of this analysis revealed high correlations between severity and threat
ratings for each illness, as well as high correlation between chronicity and
progressiveness ratings. One could conceptualize that the constructs of severity and threat
might be related, as increases in severity of an illness would logically increase the threat
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associated with the condition. Similarly, both chronicity and progressiveness refer to
changes in the disease process over time. Diseases that are more likely to persist over
time (chronic disease) could be expected to be more likely to increase in severity over
time as well (progressive illness). Given the similarity of patterns of variance based on
the combined weightings evaluated, it would be expected that invariance testing using
weights based on each individual construct would yield similar results.
Although the nature of the sample group offers a number of advantages for the
generalizability of our results, there are also several limiting factors to be noted. The
sample group consisted of older adults who sought help at primary-care clinics, and who
were willing to participate in the original study. While the literature suggests that primary
care is a preferred point of contact for older adults, there may be qualitative differences
between those elders who seek help in this manner and those who would present to other
providers, such as mental health practitioners, clinics, and emergency rooms, as well as
those who do not seek help for their symptoms. It is possible that those potential
participants who declined to participate may also differ in important ways from those
who did participate. Exclusion criteria for the final sample group limits the
generalizability of the study at both ends of the spectrum of psychopathology.
Participants who did not meet baseline criteria for anxiety, depressive, and substance use
disorders were excluded from the original study. Thus, the study sample did not allow us
to look at persons who exhibited subsyndromal anxiety and depressive symptoms. It is
crucial to include these persons in future studies, given the prevalence of
symptomatology in this population that falls short of DSM-IV diagnostic criteria, but
nevertheless results in significant distress and impairment. Conversely, potential
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participants who were already receiving treatment for an anxiety or mood disorder, or had
diagnoses of hypomanic or psychotic disorders, were also excluded. This further
restricted the range of psychopathology in the sample group. Additionally, the observed
variables in our models were created by either employing existing factor analyses (in the
case of the BAI and CES-D variables) or by summing MINI symptom questions
associated with general anxiety and depression factors. This method does not provide
information about the relationship of specific DSM disorders to the latent variables.
Additionally, this method limits the validity of the latent variables to the reliability and
validity of the observed measures. An important replication of this study would employ
different measures to represent the latent variables. In particular, the measures selected
should address some of the salient critiques of established symptom measures with older
adults. For example, the BAI has often been criticized for its over-reliance on somatic
symptoms of anxiety, which creates confounds when employed in chronically ill
populations.
This study represents an important first step in elucidating the relationship
between anxiety, depression, and comorbid medical conditions. It will be necessary,
however, to replicate these findings in a sample that addresses the limitations of the
current study. Also, these results are based on cross-sectional data. Examining these
relationships in a longitudinal design is a needed extension of this research, to further
clarify the nature of these relationships as medical illness persists and progresses. Future
studies should employ observed variables that reflect specific factors and disorder
criteria. Additionally, reliable and valid measures of the medical-illness constructs should
be employed. Also, future studies should explore anxiety and depression comorbidity
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within individual disease states. Finally, integrated models that specify the relationship
between anxiety, depression, and medical illness should be posited and tested.
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Table 1. Comparison of key demographic variables between final sample (N = 2,163)
and participants excluded for missing data1 (n = 87)
Final sample
Excluded cases
__________________________________________
N
%
N
%
__________________________________________________________________
Gender2
Male
Female
Age
65-74
75 +
Ethnicity3
White
Black
Asian
Hispanic
Native American/Other/Refused
Marital Status2
Married/partnered
Separated/divorced
Widowed
Never married
Education2
Less than high school
High school/GED
Some college or higher
Financial Status2
Cannot make ends meet
Enough to get by
Comfortable

1,622
513

76.0
24.0

68
19

78.1
21.9

1,295
868

59.9
40.1

60
27

69.3
30.7

1217
512
107
292
56

56.3
23.7
4.9
13.5
2.6

43
28
6
8
2

49.3
32.5
6.5
9.1
2.6

1089
440
510
115

50.6
20.4
23.7
5.3

39
14
23
11

45.3
16.0
26.7
12.0

916
497
740

42.3
23.0
34.2

46
16
23

53.3
18.7
26.6

436
977
707

20.2
45.2
32.7

22
53
12

25.3
60.0
13.3

NOTE: 1- Exclusion based on missing responses to MINI question M1(“ Have you
worried excessively or been anxious about several things over the past six months?”) 2Totals less than 2,163 due to option to refuse question. 3- Total exceeds 2,163 because
multiple responses were allowed.
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Table 2. Comparison of key variables of interest between final sample (N = 2,163) and
participants excluded for missing data (n = 87).
________________________________________________________________________
Confidence Intervals (95 %)
___________________________________________
Final sample
Excluded cases
___________________________________________
Variable name
Low
High
Low
High
________________________________________________________________________
CES-D well-being

1.03

15.03

-0-

13.08

CES-D somatic

-0-

12.78

0.31

21.51

CES-D anhedonia

-0-

10.99

-0-

12.63

CES-D dysphoria

-0-

16.77

-0-

21.14

BAI anxious cognitions

-0-

8.58

-0-

21.40

BAI somatic arousal

-0-

10.31

-0-

32.60

MINI summed anxiety items

-0-

12.19

2.82

13.84

MINI summed depression
-09.89
1.72
10.62
________________________________________________________________________
NOTE: CES-D—Center for Epidemiological Studies-Depression Scale; BAI—Beck
Anxiety Inventory; MINI—Mini International Neuropsychiatric Interview.
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Table 3. Mini International Neuropsychiatric Interview (MINI) diagnostic modules.
(From Sheehan et al., 2002).
________________________________________________________________________
Module
Major Depressive Episode
With melancholic features
Dysthymia
Suicidality
Manic Episode
Hypomanic Episode
Panic Disorder
Agoraphobia
Social Phobia
Obsessive-Compulsive
PTSD
Alcohol Dependence
Alcohol Abuse
Substance Dependence
Substance Abuse
Psychotic Disorders

Time Frame
Current (past two weeks)
Current (two years)
Current (past month)
Current/Past
Current/Past
Current/Lifetime
Current
Current (past month)
Current (past month)
Current (past month)
Past 12 months
Past 12 months
Past 12 months
Past 12 months
Lifetime/Current

DSM-IV Code
296.20-296.26
296.30-296.36
300.4

296.00-296.06
296.80-296.89
300.01-300.21
300.22
300.23
300.3
309.81
303.9
305.00
304.00-.90/305.20-.90
304.00-.90/305.20-.90
295.10-295.90/297.1/
297.3/293.81/293.82/
293.89/298.8/298.9
Mood disorder w/Psychotic Features Current
296.24
Anorexia Nervosa
Current (past 3 months)
307.1
Bulimia Nervosa
Current (past 3 months)
307.51
Generalized Anxiety Disorder
Current (past 6 months)
300.02
Antisocial PD
Lifetime
301.7
________________________________________________________________________
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Table 4. MINI item composition of observed variables.
________________________________________________________________________
Variable
Items and descriptions
________________________________________________________________________
MINI Positive Affect (MP)

E 2. In the past two weeks, have you been less
interested in most things, or less interested in things
you used to enjoy most of the time?
E 3 (d). Did you feel tired or without energy almost
every day?
F 3 (c). Did you feel tired or without energy?
H 2 (d).Did you feel tired or without energy almost
every day?

MINI Negative Affect (MN)

E 1. Have you been consistently depressed or down,
most of the day, nearly every day, for the past two
weeks?
E 3 (e). Did you feel worthless or guilty almost
every day?
F 3 (d). Did you lose your self-confidence?
H 2 (e). Did you feel worthless or guilty almost
every day?

MINI Physiological Arousal (MPA)

L 4 (a). Skipping, racing, or pounding heart
L 4 (b). Sweaty or clammy hands
L 4 (c). Trembling or shaking
L 4 (d). Shortness of breath
L 4 (e). Choking or lump in throat
L 4 (f). Chest pain
L 4 (g). Nausea, stomach pain, diarrhea
L 4 (h). Dizziness
L 4 (l). Tingling or numbness in body parts
L 4 (m). Hot or cold sensations

MINI Non-specific Anxiety (MNX)

L 4 (i). Feelings of unreality or detachment
L 4 (j). Losing control or “going crazy”
L 4 (k). Fear of dying
M 1 Excessive worry
M 2 Difficult to control worrying
M 3 (a). Restless, keyed-up, on edge
M 3 (b). Tense

MINI Depression (MD)

Sum of items in Modules E, F, H

MINI Anxiety (MX)

Sum of items in Modules L, M

________________________________________________________________________
NOTE: Module E—Major Depression and depression symptoms; Module F—Dysthymia;
Module H—Depression history; Module L—Panic disorder; Module M—Generalized
anxiety
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Table 5. Medical history checklist from PRISM-E baseline (N = 2,163).
________________________________________________________________________
Disease category
n
%
________________________________________________________________________
Diabetes

546

25.2

Hypertension

1389

64.2

Heart trouble

756

35.0

Vascular disease or atherosclerosis

711

32.9

Any type of paralysis

93

4.3

Any effects of stroke

162

7.5

1385

65.1

Stomach ulcer

231

10.7

COPD, emphysema, asthma

385

17.8

Glaucoma

315

14.6

Liver disease

87

4.0

Gall bladder

78

3.6

Kidney disease

202

9.3

Bladder problem

430

19.9

34

1.6

Other fractures

130

6.0

Anemia

155

7.2

43

2.0

Sleep problems

1157

53.5

Skin disorders

573

26.5

Cancer

262

12.1

Arthritis

Hip fracture

Parkinson’s disease

________________________________________________________________________
NOTE: Frequencies, percentages not cumulative.
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Table 6. Mean ratings of severity, threat, chronicity, and progressiveness for disease
categories, from survey of MSN students (N = 63)
________________________________________________________________________
Disease category
Severity
Threat
Chronicity
Progressiveness
______________________________________________________________________________________
M

SD

M

SD

M

SD

M

SD

________________________________________________
Diabetes

2.98

1.33

2.15

1.07

4.78

0.55

3.53

1.13

Hypertension

2.37

1.09

2.50

1.20

4.50

0.87

3.02

1.20

Heart trouble

3.65

1.15

3.90 1.05

4.68

0.62

3.67

1.08

Vascular disease or atherosclerosis

3.03

1.10

2.97 1.10

4.22

0.96

3.55

1.08

Any type of paralysis

3.72

1.41

2.17

1.22

4.15

1.27

2.62

1.33

Any effects of stroke

4.23

0.96

3.35

1.15

4.05

0.98

2.70

1.20

Arthritis

1.72

1.07

1.38 0.90

4.18

1.12

3.78

1.19

Stomach ulcer

1.87

0.85

1.45

0.81

2.67

1.17

1.97

0.88

COPD, emphysema, asthma

3.78

1.03

3.75 1.07

4.50

0.81

4.12

0.98

Glaucoma

1.47

0.70

1.22

0.52

3.03

1.56

2.50

1.95

Liver disease

3.40

1.12

3.40

1.03

4.02

1.03

3.67

1.05

Gall bladder

2.93

1.29

1.68

0.83

2.10

1.02

2.07

1.07

Kidney disease

3.62

1.07

3.13 1.20

3.97

1.16

3.63

1.19

Bladder problem

2.13

1.05

1.55 0.81

2.53

1.08

2.30

1.10

Hip fracture

4.00

1.25

1.97 1.08

2.80

1.27

2.03

1.17

Other fractures

2.80

1.37

1.58 0.94

2.10

1.10

1.53

0.89

Anemia

2.27

1.23

1.77 0.90

2.95

1.37

2.03

1.12

Parkinson’s disease

2.97

1.34

2.28 1.37

4.32

1.08

4.12

1.24

Sleep problems

1.63

0.92

1.27 0.63

2.55

1.38

2.03

1.06

Skin disorders

1.47

0.82

1.25 0.65

2.30

1.38

1.98

1.14

Cancer

4.30

1.01

4.18 0.92

4.45

0.93

3.68

1.14

Cataracts

1.40

0.74

1.21 0.64

2.50

1.35

2.42

1.38

________________________________________________________________________
NOTE: Severity ratings—1= 0-20 % likelihood of hospitalization, 2 = 21-40 %
likelihood, 3 = 41-60 % likelihood, 4 = 61-80 % likelihood, 5 = 81-100% likelihood;
Threat Ratings--1 = 0-20 % likelihood of death, 2 = 21-40% likelihood, 3 = 41-60 %
likelihood, 4 = 61-80 % likelihood, 5 = 81-100% likelihood; Chronicity Ratings--1 = 020 % likelihood of continued illness, 2 = 21-40% likelihood, 3 = 41-60 % likelihood, 4 =
61-80 % likelihood, 5 = 81-100% likelihood; Progressiveness Ratings--1 = 0-20 %
likelihood of increasing severity, 2 = 21-40% likelihood, 3 = 41-60 % likelihood, 4 = 6180 % likelihood, 5 = 81-100% likelihood.
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Table 7. Intercorrelations for observed variables for all models.
________________________________________________________________________
1

2

3

4

5

6

7

8

9

10

11

12

________________________________________________________________________
1. BAC

--

2. BS

.78

--

3. MX

.65

.59

4. MPA

.26

.27 .60

5. MNX

.23

.20 .54 .55

--

6. MD

.26

.24 .28 .12

.09

7. MP

.18

.19 .19

8. MN

.24

.22

9. CS

.31

.30 .28

.12 .10

.71 .63

.55

10. CA

.23

.22 .24

.08 .07

.61 .50

.55 .57

--

11. CD

.31

.25 .27

.11 .11

.67 .54

.65 .73

.65

12. CW

---

.06 .051 .79

--

.032 .74

.50

.21 .06

-.23 -.22 -.24

-----

-.08 -.07 -.61 -.50 -.55 -.58 -1.00 -.65

--

________________________________________________________________________
NOTE: 1—p < .05; 2—Non-significant. All other correlations significant at p < .01.
BAC—BAI anxious cognitions; BS—BAI somatic; MX—MINI summed anxiety; MPA—
MINI physiological arousal; MNX—MINI non-specific anxiety; MD—MINI summed
depression; MP—MINI positive affect; MN—MINI negative affect: CS—CES-D somatic;
CA—CES-D anhedonia; CD—CES-D dysphoria; CW—CES-D well-being.
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Table 8. Descriptive statistics for study variables (N =2163).
________________________________________________________________________
Range
________________________
Variable name
M
SD
Low
High
________________________________________________________________________
CES-D well-being

8.04

3.58

-0-

12.00

CES-D somatic

7.40

5.40

-0-

21.00

CES-D anhedonia

3.96

3.58

-0-

12.00

CES-D dysphoria

6.19

5.41

-0-

21.00

BAI anxious cognitions

1.90

3.42

-0-

20.00

BAI somatic arousal

3.80

6.53

-0-

31.00

MINI physiological arousal

0.36

1.52

-0-

10.00

MINI nonspecific anxiety

0.12

0.74

-0-

7.00

MINI positive affect

1.29

0.87

-0-

3.00

MINI negative affect

0.82

0.80

-0-

3.00

MINI summed anxiety items

2.45

3.72

-0-

22.00

MINI summed depression
4.44
2.78
-017.00
________________________________________________________________________
NOTE: CES-D—Center for Epidemiological Studies-Depression Scale; BAI—Beck
Anxiety Inventory; MINI—Mini International Neuropsychiatric Interview.
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Table 9. Fit indices for measurement models with full PRISM-E sample (N = 2,163).
________________________________________________________________________
Model
χ2
df
χ2/df
GFI
AGFI
RMSEA
________________________________________________________________________
Tripartite

10.397*

3

3.466

0.998

0.989

0.034

Burns-Eidelson

588.542** 33

17.835

0.955

0.910

0.082

Hierarchical

21.255**

4.251

0.997

0.986

0.039

5

________________________________________________________________________
NOTE: * p < 0.05; ** p < 0.01.
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Table 10. Fit indices for structural models with full PRISM-E sample (N = 2,163).
________________________________________________________________________
Model
χ2
df
χ2/df
GFI
AGFI
RMSEA
________________________________________________________________________
Tripartite1
Burns-Eidelson
Hierarchical

10.397*

3

3.466

0.998

0.989

0.034

5489.248** 34

161.449

0.750

0.596

0.272

3.790

0.997

0.988

0.036

22.737**

6

________________________________________________________________________
NOTE: * p < 0.05; ** p < 0.01. 1Statistics for this model are same as for measurement
model, since all latent variables are first-order.
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Table 11. Fit test summary for invariance between low and high medical illness
severity/threat subsamples.
________________________________________________________________________
Model description
χ2
df
∆χ2
∆df
p
________________________________________________________________________
1. Hypothesized baseline model

36.437

12

---

---

---

2. Factor loadings, variances
and covariances constrained
equal

260.308

21

223.871

9

0.0001

3. Factor loadings constrained
equal

55.667

16

19.230

4

0.0007

4. Depression factor loadings
constrained equal

36.474

13

0.037

1

NS

5. Depression factors, plus all
anxiety factors except BS
constrained equal

41.882

15

5.445

3

NS

6. Depression factors, plus all
anxiety factors except MX
constrained equal

54.924

15

18.487

3

0.0003

7. Depression factors, plus all
anxiety factors except BAC
51.153
15
14.716
3
0.0021
constrained equal
________________________________________________________________________
NOTE: ∆χ2 = difference in χ2 values. ∆df = difference in degrees of freedom. All
comparisons to Model 1.
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Table 12. Fit test summary for invariance between low and high medical illness
chronicity/progressiveness subsamples.
________________________________________________________________________
Model description
χ2
df
∆χ2
∆df
p
________________________________________________________________________
1. Hypothesized baseline model

36.281

12

---

---

2. Factor loadings, variances
and covariances constrained
equal

278.582

21

242.300

9

0.0001

3. Factor loadings and latent
paths constrained equal

98.143

18

61.862

6

0.0001

4. Anxiety factor loadings and
latent paths constrained equal

76.409

17

40.128

1

0.0001

41.882

15

5.445

3

0.0001

36.482

13

0.539

3

NS

7. Depression factors, plus all
anxiety factors except BAC
constrained equal

50.540

15

14.259

3

0.0026

8. Depression factors, plus all
anxiety factors except MX
constrained equal

55.023

15

18.742

3

0.003

5. Depression factor loadings
and latent paths
constrained equal
6. Depression factors only
constrained equal

---

9. Depression factors, plus all
anxiety factors except BS
39.946
15
3.665
3
NS
constrained equal
________________________________________________________________________
NOTE: ∆χ2 = difference in χ2 values. ∆df = difference in degrees of freedom. All
comparisons to Model 1.
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Figure 1. Measurement model for the Cook et al. (2004) tripartite structural model.

e_cw
e_mp

e_cd
e_bac

e_cs
e_bs

1
1

1
1

1
1

cw
1

Positive affect

1

Negative affect

1

Physiological
hyperarousal

mp

cd
bac
cs
bs

NOTE: All paths are significant p < .01. CW—CES-D ‘well-being’ items; MP—MINI
‘positive affect’ items; CD—CES-D ‘dysphoria’ items; BAC—BAI ‘anxious cognition’s
items; CS—CES-D ‘somatic’ items; BS—BAI ‘somatic arousal’ items.
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Figure 2. Measurement model for Burns and Eidelson’s (1998) two-factor model.

e_cs
e_ca
e_mp

e_md
e-cd
e_mn

e_bac
e_mx
e_mnx

e_bs
e_mpa

1

cs

1

ca

1

1

mp

1

Anhedonia

1

Nonspecific
depression

1

Nonspecific
anxiety

md

1

cd

1

mn

1
1
1

1
1

bac
mx
mnx
bs
mpa

1

Somatic
arousal

NOTE: All paths significant at p < .01. CS—CES-D somatic items; CA—CES-D
anhedonia items; MP—MINI items indicating positive affect; MD—MINI summed
depression items; CD—CES-D dysphoria items; MN—MINI negative affect items; BAC—
BAI anxious cognitions items; MX—MINI summed anxiety items; MNX—MINI nonspecific anxiety items; BS—BAI somatic arousal items; MPA—MINI items indicating
physiological arousal.
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Figure 3. Measurement model for Meeks et al. (2003) hierarchical three-factor model.

e_cw

e_md

e_bac

e_mx
e_bs
e_cs

1

1

1
1
1
1

cw

1

Depression
md

bac
mx
bs

Anxiety
1

cs

NOTE: All paths significant at p < .01. CW—CES-D well-being; MD—MINI depression
items; BAC—BAI anxious cognitions; MX—MINI anxiety items; BS-BAI somatic arousal;
CS—CES-D somatic.
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Figure 4. Structural two-factor model from Burns and Eidelson (1998).
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Somatic
arousal
1

1

mpa

1

1

d_sa

NOTE: All paths significant at p < .01. CS—CES-D somatic items; CA—CES-D
anhedonia items; MP—MINI items indicating positive affect; MD—MINI summed
depression items; CD—CES-D dysphoria items; MN—MINI negative affect items; BAC—
BAI anxious cognitions items; MX—MINI summed anxiety items; MNX—MINI nonspecific anxiety items; BS—BAI somatic arousal items; MPA—MINI items indicating
physiological arousal.
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Figure 5. Structural model for hierarchical model (Meeks et al., 2003).
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1
e_cw
e_md

1

1

cw

1

Depression
md

1

d_a
e_bac
e_mx
e_bs
e_cs

1
1
1
1

bac

Negative
affect

1

mx
bs

1

Anxiety
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NOTE: All paths significant at p < .01. CW—CES-D well-being; MD—MINI depression
items; BAC—BAI anxious cognitions; MX—MINI anxiety items; BS-BAI somatic arousal;
CS—CES-D somatic.
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Figure 6. Hierarchical model displaying correlations for regression paths-high
severity/threat sample (n = 750).
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1
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1.00
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NOTE: All paths significant at p < .01. CW—CES-D well-being; MD—MINI depression
items; BAC—BAI anxious cognitions; MX—MINI anxiety items; BS-BAI somatic arousal;
CS—CES-D somatic.
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Figure 7. Hierarchical model displaying correlations for regression paths-low
severity/threat sample (n = 705).
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1
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Negative
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1.00
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NOTE: All paths significant at p < .01. CW—CES-D well-being; MD—MINI depression
items; BAC—BAI anxious cognitions; MX—MINI anxiety items; BS-BAI somatic arousal;
CS—CES-D somatic.
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Figure 8. Hierarchical model displaying correlations for regression paths-high
chronicity/progressiveness sample (n = 733).
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NOTE: All paths significant at p < .01. CW—CES-D well-being; MD—MINI depression
items; BAC—BAI anxious cognitions; MX—MINI anxiety items; BS-BAI somatic arousal;
CS—CES-D somatic.
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Figure 9. Hierarchical model displaying correlations for regression paths-low
chronicity/progressiveness sample (n = 716).
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NOTE: All paths significant at p < .01. CW—CES-D well-being; MD—MINI depression
items; BAC—BAI anxious cognitions; MX—MINI anxiety items; BS-BAI somatic arousal;
CS—CES-D somatic.
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Appendix
ILLNESS PERCEPTIONS SURVEY
Thank you for participating in this survey. We are interested in your perceptions, as a
healthcare provider, of the severity, threat level, chronicity, and progressiveness of a
number of diagnostic categories commonly observed in older adults. For this survey, the
term ‘older adults’ will be defined as age 65 or older.
Severity is defined as the likelihood that a person suffering from this condition would
require one or more days of hospitalization. For each category, use the following rating
scale:
1 = 0-20 % likelihood of hospitalization
2 = 21-40 % likelihood
3 = 41-60 % likelihood
4 = 61-80 % likelihood
5 = 81-100% likelihood
Threat level is defined as the likelihood that sequelae of diseases in this category would
result in the death of the patient. For each category, use the following scale:
1 = 0-20 % likelihood
2 = 21-40% likelihood
3 = 41-60 % likelihood
4 = 61-80 % likelihood
5 = 81-100% likelihood
Chronicity is defined as the likelihood that the disease will require medical treatment,
beyond that which the patient could independently manage, for 6 months or longer.
For each category, use the following scale:
1 = 0-20 % likelihood
2 = 21-40% likelihood
3 = 41-60 % likelihood
4 = 61-80 % likelihood
5 = 81-100% likelihood
Progressiveness is defined as the likelihood that diseases in this category will increase in
severity over time, regardless of treatment. For each category, use the following scale:
1 = 0-20 % likelihood
2 = 21-40% likelihood
3 = 41-60 % likelihood
4 = 61-80 % likelihood
5 = 81-100% likelihood
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Disease category

Severity

Threat

Chronicity

Progressiveness

Diabetes

_____

_____

_____

_____

Hypertension

_____

_____

_____

_____

Heart disease

_____

_____

_____

_____

Vascular disease
(peripheral or atherosclerosis)

_____

_____

_____

_____

Paralysis (any etiology)

_____

_____

_____

_____

Stroke

_____

_____

_____

_____

Arthritis

_____

_____

_____

_____

Stomach ulcer

_____

_____

_____

_____

COPD

_____

_____

_____

_____

Glaucoma

_____

_____

_____

_____

Cancer

_____

_____

_____

_____

Cataracts

_____

_____

_____

_____

Liver disease

_____

_____

_____

_____

Gall bladder

_____

_____

_____

_____

Kidney disease

_____

_____

_____

_____

Bladder problems

_____

_____

_____

_____

Hip fracture

_____

_____

_____

_____

Other fractures

_____

_____

_____

_____

Anemia

_____

_____

_____

_____

Parkinsons’ disease

_____

_____

_____

_____

Sleep disorders

_____

_____

_____

_____

Skin conditions

_____

_____

_____

_____
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Please answer the following demographic questions.
1. What is your age?
1 = 18-30
2 = 31-40
3 = 41-50
4 = 51-60
5 = < 60 years
2. What is your level of clinical experience?
1 = 0-1 years
2 = 1-5 years
3 = 5-10 years
4 = 10-15 years
5 = < 15 years
3. What is your identified race/ethnicity? (optional—for research purposes only)
1 = African-American/Native African
2 = Asian/Pacific Islander
3 = Caucasian/European
4 = Latin American/Hispanic
5 = Native American/Alaskan
6 = Biracial or multiracial
4. What is your identified gender? (optional—for research purposes only)
1 = Male
2 = Female

